康哲药业(00867.HK)拟8月18日举行董事会会议批准中期业绩
Group 1 - The company, Kangzheng Pharmaceutical (00867.HK), has announced a board meeting scheduled for August 18, 2025, to consider and approve the interim results for the six months ending June 30, 2025 [1] - The board meeting will also consider the distribution of an interim dividend, if applicable [1]